ロード中...
Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
BACKGROUND: To determine the 5-year outcome after high-dose-rate brachytherapy (HDR-BT) as a monotherapy. METHODS: Between 10/2003 and 06/2006, 36 patients with low (28) and intermediate (8) risk prostate cancer were treated by HDR-BT monotherapy. All patients received one implant and 4 fractions of...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4046044/ https://ncbi.nlm.nih.gov/pubmed/24885327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-9-122 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|